SEI Investments
APGE

SEI Investments’s Apogee Therapeutics APGE Stock Holding History

SEI Investments’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
9,023
-33,180
-79% -$2.99M ﹤0.01% 2214
2026
Q1 		$3.55M Buy
42,203
+25,874
+158% +$1.88M ﹤0.01% 1725
2025
Q4 		$1.23M Buy
+16,329
New +$1.03M ﹤0.01% 2084
2024
Q2 		– Sell
-9,751
Closed -$648K – 2656
2024
Q1 		$648K Buy
+9,751
New +$426K ﹤0.01% 2027

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

SEI Investments's APGE Position: Q2 2026 in Review

SEI Investments reduced its Apogee Therapeutics (APGE) stake by 79% in Q2 2026, selling an estimated $2.99M and leaving 9,023 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2214.

SEI Investments first reported a position in APGE in Q1 2024 and has held it in 4 quarters since. The position peaked at $3.55M in Q1 2026. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • SEI Investments held 9,023 shares of Apogee Therapeutics worth $1.2M as of Q2 2026.
  • SEI Investments sold 33,180 Apogee Therapeutics shares in Q2 2026, an estimated $2.99M.
  • Apogee Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2214 holding.
  • SEI Investments first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • SEI Investments's Apogee Therapeutics position peaked at $3.55M in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.